Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula.
The ongoing COVID-19 pandemic is a persistent challenge, with continued breakthrough infections despite vaccination efforts. This has spurred interest in alternative preventive measures, including dietary and herbal interventions. Previous research has demonstrated that herbal medicines can not only inhibit cancer progression but also combat viral infections, including COVID-19 by targeting ... SARS-CoV-2, indicating a multifaceted potential to address both viruses and cancer. Here, we found that the Kang Guan Recipe (KGR), a novel herbal medicine formula, associates with potent inhibition activity against the SARS-CoV-2 viral infection. We demonstrate that KGR exhibits inhibitory activity against several SARS-CoV-2 variants of concern (VOCs). Mechanistically, we found that KGR can block the interaction of the viral spike and human angiotensin-converting enzyme 2 (ACE2). Furthermore, we assessed the inhibitory effect of KGR on SARS-CoV-2 viral entry in vivo, observing that serum samples from healthy human subjects having taken KGR exhibited suppressive activity against SARS-CoV-2 variants. Our investigation provides valuable insights into the potential of KGR as a novel herbal-based preventive and therapeutic strategy against COVID-19.
Mesh Terms:
Angiotensin-Converting Enzyme 2, Animals, Antiviral Agents, COVID-19, COVID-19 Drug Treatment, Chlorocebus aethiops, Drugs, Chinese Herbal, Humans, SARS-CoV-2, Spike Glycoprotein, Coronavirus, Vero Cells, Virus Internalization
Angiotensin-Converting Enzyme 2, Animals, Antiviral Agents, COVID-19, COVID-19 Drug Treatment, Chlorocebus aethiops, Drugs, Chinese Herbal, Humans, SARS-CoV-2, Spike Glycoprotein, Coronavirus, Vero Cells, Virus Internalization
Cancer Lett
Date: Nov. 01, 2024
PubMed ID: 39197583
View in: Pubmed Google Scholar
Download Curated Data For This Publication
253846
Switch View:
- Interactions 1